Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal composition and preparation method thereof

A composition and drug technology, applied in the directions of drug combinations, active ingredients of heterocyclic compounds, cardiovascular system diseases, etc., can solve the problems of difficult industrial production, high energy consumption of dry granulation, high equipment requirements, and overcome mutual constraints. , The effect of smooth granulation process and low equipment requirements

Inactive Publication Date: 2012-07-04
BEIJING D VENTUREPHARM TECH DEV
View PDF2 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, dry granulation has the disadvantages of high energy consumption, small adaptability, high requirements for equipment or the need to renovate workshops, and certain dust pollution, making industrial production difficult.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition and preparation method thereof
  • Medicinal composition and preparation method thereof
  • Medicinal composition and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicinal composition. The medicinal composition consists of the following ingredients in percentage by weight: 1 to 5 percent of amlodipine and pharmaceutically acceptable salt thereof, 20 to 50 percent of valsartan, 1 to 10 percent of hydrochlorothiazide, 20 to 50 percent of filling agent, 8 to 24 percent of disintegrating agent, 0.01 to 0.06 percent of adhesive 1, 0.01 to 0.2 percent of adhesive 2, 0.3 to 2 percent of flow aid and 0.5 to 2.5 percent of lubricating agent. The medicinal composition has the advantages of simple preparation process, low equipment requirement, simplicity in operation and small dust pollution, guarantees the quality of medicines and contributes to industrialized production.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating hypertension and a preparation method thereof, in particular to a pharmaceutical composition containing amlodipine and a pharmaceutically acceptable salt thereof, valsartan and hydrochlorothiazide and a preparation method thereof. Background technique [0002] Hypertension is a common cardiovascular disease and can induce or aggravate other related diseases. At present, about 2 / 3 of hypertensive patients need to take two or more antihypertensive drugs to control blood pressure. Various clinical studies have shown that the use of drug combinations is one way to achieve desired therapeutic endpoints. The solid preparation of compound amlodipine valsartan hydrochlorothiazide is a safe and oral effective antihypertensive drug widely used in clinic. Amlodipine valsartan not only provides two powerful antihypertensive drugs, but also significantly reduces adverse reactions, and is convenie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/549A61K31/4422A61K31/41A61K47/38A61K47/10A61P9/12
Inventor 黄雪吕青远
Owner BEIJING D VENTUREPHARM TECH DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products